NewStar Financial Inc (NASDAQ:NEWS) Reports First Quarter Consolidated Net Income of $6.2 Million, or $0.12 Per Diluted. New funded loan volume was $275 million, up $130 million or 90% from the first quarter of 2013. Net Interest Margin – Margin widened slightly to 3.50% for the fourth quarter from 3.41% due to increased interest income on higher average loan balances. Revenue – Risk-adjusted revenue1 was up slightly from the prior quarter to $22.7 million as gains from the sale of equity interests retained in restructurings of impaired loans offset higher credit costs NewStar Financial Inc (NASDAQ:NEWS) net profit margin is 18.60% and weekly performance is -0.73%. On last trading day company shares ended up $10.91. Analysts mean target price for the company is $14.00. NewStar Financial Inc (NASDAQ:NEWS) distance from 50-day simple moving average (SMA50) is -10.70%.
Many investors appear to be quite bearish on Onconova Therapeutics Inc (NASDAQ:ONTX), especially if you look at the percentage of the float that is sold short for this stock. Currently, 23.7% of the float is sold short, suggesting an extreme level of bearishness for ONTX.
However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we have a Zacks Rank #2 (Buy) on ONTX, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of ONTX to move higher in the weeks ahead. Onconova Therapeutics Inc (NASDAQ:ONTX) shares fell -0.75% in last trading session and ended the day on $5.28. ONTX return on assets is -72.70%. Onconova Therapeutics Inc (NASDAQ:ONTX) quarterly performance is -64.99%.
Eagle Pharmaceuticals Inc (NASDAQ:EGRX) announced that the Company will release its 2014 second quarter financial results on Wednesday, May 14, 2014, before the market opens. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) shares moved down -0.21% in last trading session and was closed at $9.38, while trading in range of $9.16 – $9.52. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) year to date (YTD) performance is -26.89%.
On May 5, 2014, Gladstone Land Corp (NASDAQ:LAND) reported financial results for the first quarter ended March 31, 2014. A description of funds from operations (“FFO”), a relative non-GAAP (generally accepted accounting principles in the United States) financial measure, is located at the end of this press release. All per-share references are to fully-diluted, weighted average shares of common stock unless otherwise noted. Please read the Company’s Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the “SEC”. Gladstone Land Corp (NASDAQ:LAND) ended the last trading day at $11.54. Company weekly volatility is calculated as 5.26% and price to cash ratio as 4.62. Gladstone Land Corp (NASDAQ:LAND) showed a negative weekly performance of -7.01%.